Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:52:04.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section including Missouri (St. Louis, MO) for the study page and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:54:33.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no changes to study details or page layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:22:20.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Minor software revision from v3.2.0 to v3.3.1; no changes to trial content or displayed information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:59:39.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Removed the government funding status notice. The study details on the page remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T07:14:58.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Core study information remains the same between screenshots, including title, identifier (NCT04543279), status, eligibility criteria, interventions, and primary/secondary outcomes. Only minor layout or styling changes are visible.
    Difference
    0.4%
    Check dated 2025-11-03T01:26:31.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.